Stock Post

Crispr Therapeutics

CRSP
$
--
Refresh Page to Update
Bullish
Bullish

Stock Post

CRISPR Technology is a revolutionary gene-editing method that can precisely modify or remove regions of DNA. This technology has many applications and could potentially create a trillion dollar market. Crispr Therapeutics is currently developing gene therapies for blood disorders, immuno-oncology and diabetes; and they have already shown promising results in their first clinical trials - with all 10 patients in the CTX001 trials exhibiting a strong improvement in quality of life, with minimal side effects. These promising initial results, combined with the companies' partnership with Vertex Pharma and its fast-tracked status in many countries, give Crispr Therapuetics a good chance of capturing some of this potentially massive new market.

9

/ 10
Technology
9

/ 10
Market
7

/ 10
Risk
8.3
/ 10
--
Disruption
Score
Get full access to this stock post and associated disruption score analysis - along with much more.
image/svg+xml
Have questions? Check out our FAQ page.
image/svg+xml
Disclosure: A member of our team is invested in this stock.
image/svg+xml
Have questions? Check out our FAQ page.
image/svg+xml
Disclosure: A member of our team is invested in this stock.
May 3
2021
This is the date when this was posted.
Hover to Learn More
Tap to Learn More
$
122.25
This is the price of
Crispr Therapeutics
stock when this was posted.
Hover to Learn More
Tap to Learn More
This is the % change of
Crispr Therapeutics
stock price since this was posted.
Hover to Learn More | Refresh Page to Update
Tap to Learn More
--
%
Show Full Post
No items found.
New 
Stock Post
CRSP
Profile picture for christopher scherz
Disruption Score
8.3
image/svg+xml
image/svg+xml
Genetics
Bullish
Stock Post For
Crispr Therapeutics
Update For
Crispr Therapeutics
filter-a
No items found.
Get full access to the feed and much more.
Filter Feed By
Stocks
(For Subscribers)
Updates
(For Subscribers)
Stocks
Updates
Ideas
Shared Content